Scynexis (SCYX) Other Non Operating Income (2014 - 2026)

Scynexis (SCYX) reported Other Non Operating Income of $354000.0 for Q1 2026, up 11700.0% quarter-over-quarter from $3000.0 in Q4 2022.

Scynexis (SCYX) Other Non Operating Income (2014 - 2026) Analysis & Trends

Scynexis has reported Other Non Operating Income for 6 years, with the latest figure at $354000.0 in Q1 2026.

For the quarter ending Q1 2026, Other Non Operating Income changed N/A year-over-year to $354000.0; the trailing twelve-month figure through Mar 2026 stood at $354000.0 (up 11700.0% YoY), and the FY2024 full-year result was $235000.0, changed N/A from the prior year.
Other Non Operating Income for Q1 2026 stood at $354000.0, up from $3000.0 in the prior quarter.
The five-year high for Other Non Operating Income was $354000.0 in Q1 2026, with the low at $3000.0 in Q4 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Teva Pharmaceutical Industries	39.72 Bn	35.98 Bn	1.97 Bn
2	Zoetis	34.61 Bn	32.67 Bn	1.62 Bn
3	United Therapeutics	24.07 Bn	21.91 Bn	648.10 Mn
4	Aurora Cannabis	16.98 Bn	16.91 Bn	33.43 Mn
5	Neurocrine Biosciences	16.64 Bn	15.32 Bn	800.70 Mn
6	Elanco Animal Health	12.19 Bn	11.76 Bn	785.00 Mn
7	Alkermes	7.37 Bn	6.86 Bn	-116.06 Mn
8	Hims & Hers Health	6.62 Bn	5.87 Bn	396.79 Mn
9	Lantheus Holdings	6.47 Bn	5.97 Bn	230.92 Mn
10	Scynexis	225.23 Mn	165.97 Mn	-

Download Data